191 related articles for article (PubMed ID: 34792179)
1. Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
Liang X; Xia R
Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34792179
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of SMIM3 inhibits growth of leukemia via PI3K-AKT signaling pathway and correlates with prognosis of adult acute myeloid leukemia with normal karyotype.
Liu Y; Chen Y; Liu Y; Li M; Zhang Y; Shi L; Yang L; Li T; Li Y; Jiang Z; Liu Y; Wang C; Wang S
J Transl Med; 2022 Dec; 20(1):612. PubMed ID: 36550462
[TBL] [Abstract][Full Text] [Related]
3. Regulatory role of RBM39 in acute myeloid leukemia: Mediation through the PI3K/AKT pathway.
Zhang X; Yang L; Liu X; Nie Z; Liu M; Wang T; Lu Y; Pan Y; Zhan Y; Wang Z; Luo J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119607. PubMed ID: 37852323
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway.
Yin H; Cui X
Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501
[No Abstract] [Full Text] [Related]
5. The molecular mechanism of kinesin family member 2A (KIF2A) underlying non-small cell lung cancer: the effect of its knockdown on malignant behaviors, stemness, chemosensitivity, and potential regulated signaling pathways.
Chen J; Wen J; Liu D; Xu X; Fan M; Zhang Z
Am J Transl Res; 2022; 14(1):68-85. PubMed ID: 35173830
[TBL] [Abstract][Full Text] [Related]
6. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
[TBL] [Abstract][Full Text] [Related]
7. Association of kinesin family member 2A with increased disease risk, deteriorative clinical characteristics, and shorter survival profiles in acute myeloid leukemia.
Ding T; Li J; Sun J; Fan X; Shi C; Zhou D; Deng R
Braz J Med Biol Res; 2020; 54(2):e9173. PubMed ID: 33331418
[TBL] [Abstract][Full Text] [Related]
8. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
[TBL] [Abstract][Full Text] [Related]
9. Silencing Kif2a induces apoptosis in squamous cell carcinoma of the oral tongue through inhibition of the PI3K/Akt signaling pathway.
Wang K; Lin C; Wang C; Shao Q; Gao W; Song B; Wang L; Song X; Qu X; Wei F
Mol Med Rep; 2014 Jan; 9(1):273-8. PubMed ID: 24248467
[TBL] [Abstract][Full Text] [Related]
10. Kinesin family member 2A links with advanced tumor stage, reduced chemosensitivity and worse prognosis in gastric cancer.
Bai F; He Z; Zhou H; Gan W
J Clin Lab Anal; 2022 May; 36(5):e24313. PubMed ID: 35313389
[TBL] [Abstract][Full Text] [Related]
11. Cobalt chloride induces RhoA/ROCK activation and remodeling effect in H9c2 cardiomyoblasts: Involvement of PI3K/Akt and MAPK pathways.
Cheng CI; Lee YH; Chen PH; Lin YC; Chou MH; Kao YH
Cell Signal; 2017 Aug; 36():25-33. PubMed ID: 28435089
[TBL] [Abstract][Full Text] [Related]
12. BDNF/PI3K/Akt and Nogo-A/RhoA/ROCK signaling pathways contribute to neurorestorative effect of Houshiheisan against cerebral ischemia injury in rats.
Chang J; Yao X; Zou H; Wang L; Lu Y; Zhang Q; Zhao H
J Ethnopharmacol; 2016 Dec; 194():1032-1042. PubMed ID: 27833029
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA LINC00265 predicts the prognosis of acute myeloid leukemia patients and functions as a promoter by activating PI3K-AKT pathway.
Ma L; Kuai WX; Sun XZ; Lu XC; Yuan YF
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7867-7876. PubMed ID: 30536332
[TBL] [Abstract][Full Text] [Related]
14. [Corrigendum] Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.
Liang X; Xia R
Oncol Rep; 2023 Feb; 49(2):. PubMed ID: 36524357
[TBL] [Abstract][Full Text] [Related]
15. [Effect of Long Non-Coding RNA LINC01268 on the Malignant Biological Behaviors of Acute Myeloid Leukemia Cells].
Chen W; Gan DY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1608-1616. PubMed ID: 38071035
[TBL] [Abstract][Full Text] [Related]
16. Tumor suppressor miR-139-5p targets Tspan3 and regulates the progression of acute myeloid leukemia through the PI3K/Akt pathway.
Zhang R; Tang P; Wang F; Xing Y; Jiang Z; Chen S; Meng X; Liu L; Cao W; Zhao H; Ma P; Chen Y; An C; Sun L
J Cell Biochem; 2019 Mar; 120(3):4423-4432. PubMed ID: 30367526
[TBL] [Abstract][Full Text] [Related]
17. The role of MACF1 on acute myeloid leukemia cell proliferation is involved in Runx2-targeted PI3K/Akt signaling.
Wang P; Zhang J; Zhang H; Zhang F
Mol Cell Biochem; 2023 Mar; 478(3):433-441. PubMed ID: 35857251
[TBL] [Abstract][Full Text] [Related]
18. Circ_0009910 sponges miR-491-5p to promote acute myeloid leukemia progression through modulating B4GALT5 expression and PI3K/AKT signaling pathway.
Wu Y; Zhao B; Chen X; Geng X; Zhang Z
Int J Lab Hematol; 2022 Apr; 44(2):320-332. PubMed ID: 34709725
[TBL] [Abstract][Full Text] [Related]
19. miR-338-3p Plays a Significant Role in Casticin-Induced Suppression of Acute Myeloid Leukemia via Targeting PI3K/Akt Pathway.
Yu K; Wang J; Hou J; Zhang L; Liang H
Biomed Res Int; 2022; 2022():9214130. PubMed ID: 35765408
[TBL] [Abstract][Full Text] [Related]
20. Autocrine IGF-1/IGF-1R signaling is responsible for constitutive PI3K/Akt activation in acute myeloid leukemia: therapeutic value of neutralizing anti-IGF-1R antibody.
Chapuis N; Tamburini J; Cornillet-Lefebvre P; Gillot L; Bardet V; Willems L; Park S; Green AS; Ifrah N; Dreyfus F; Mayeux P; Lacombe C; Bouscary D
Haematologica; 2010 Mar; 95(3):415-23. PubMed ID: 20007139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
